Literature DB >> 7995191

Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis.

L H Simpson1, M Battegay, J H Hoofnagle, J G Waggoner, A M Di Bisceglie.   

Abstract

We studied 28 patients with chronic delta hepatitis for the presence of hepatitis delta virus (HDV) RNA in serum. The hot start polymerase chain reaction (PCR) method, in which the reaction begins at 60-80 degrees C, showed a higher sensitivity than conventional PCR reaction. Additionally, the presence of hepatitis B (HBV) and C virus (HCV) infections were determined by PCR. HDV RNA was detected in 26 patients (93%), HBV DNA in 22 (79%), and HCV RNA in only one. Detection of HDV RNA correlated very well with detection of hepatitis delta antigen by immunostaining in the liver. In six patients HDV RNA was detectable despite the absence of HBV DNA in serum, suggesting that high levels of HBV are not required for HDV replication. Of 29 control patients with chronic hepatitis B without antibody to HDV, none had detectable HDV RNA, while all had HBV DNA in serum. Detection of HDV RNA with PCR proved highly sensitive and specific, demonstrating that virtually all patients with chronic HDV infection had ongoing viral replication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995191     DOI: 10.1007/BF02087704

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

1.  Evaluation of hepatitis delta virus RNA levels during interferon therapy by analysis of polymerase chain reaction products with a nonradioisotopic hybridization assay.

Authors:  E Cariani; A Ravaggi; M Puoti; G Mantero; A Albertini; D Primi
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

Review 2.  Interactions of the human immunodeficiency virus and the hepatotropic viruses.

Authors:  A N McNair; J Main; H C Thomas
Journal:  Semin Liver Dis       Date:  1992-05       Impact factor: 6.115

3.  Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications.

Authors:  Q Chou; M Russell; D E Birch; J Raymond; W Bloch
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

Review 4.  Hepatitis delta: the virus and the disease.

Authors:  M Rizzetto
Journal:  J Hepatol       Date:  1990       Impact factor: 25.083

5.  Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets.

Authors:  K Cristiano; A M Di Bisceglie; J H Hoofnagle; S M Feinstone
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

6.  Sensitive enzyme immunoassay for the detection of delta antigen and anti-delta, using serum as the delta antigen source.

Authors:  A G Shattock; B M Morgan
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

7.  Chronic delta hepatitis: detection of hepatitis delta virus antigen in serum by immunoblot and correlation with other markers of delta viral replication.

Authors:  M Buti; R Esteban; R Jardi; F Rodriguez-Frias; J Casacuberta; J I Esteban; E Allende; J Guardia
Journal:  Hepatology       Date:  1989-12       Impact factor: 17.425

8.  Relapse of acute B viral hepatitis--role of delta agent.

Authors:  S Govindarajan; B Valinluck; L Peters
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

9.  delta Antigen in hepatitis B: immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection.

Authors:  E Stöcklin; F Gudat; G Krey; U Dürmüller; M Gasser; M Schmid; G Stalder; L Bianchi
Journal:  Hepatology       Date:  1981 May-Jun       Impact factor: 17.425

10.  Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique.

Authors:  S Kaneko; S M Feinstone; R H Miller
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

View more
  1 in total

1.  Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C.

Authors:  M E Eyster; J C Sanders; M Battegay; A M Di Bisceglie
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.